Koninklijke Philips NV ADR(PHG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 10 at 4:00 PM ET (Korea 9/11 05:00)
Full metrics table
| Index | - | P/E | 18.33 | EPS (ttm) | 1.34 | Insider Own | 0.01% | Shs Outstand | 977.4M | Perf Week | -6.71% |
| Market Cap | 24.04B | Forward P/E | 12.87 | EPS next Y | 2.04% | Insider Trans | - | Shs Float | 977.3M | Perf Month | -9.06% |
| Enterprise Value | 30.57B | PEG | 2.29 | EPS next Q | 0.41 | Inst Own | 5.27% | Short Float | 0.25% | Perf Quarter | -4.17% |
| Income | 1.30B | P/S | 1.17 | EPS this Y | 0.76% | Inst Trans | 1.86% | Short Ratio | 2.37 | Perf Half Y | -14.61% |
| Sales | 20.60B | P/B | 1.84 | EPS next 5Y | 5.62% | ROA | 4.21% | Short Interest | 2.42M | Perf YTD | -9.16% |
| Book/sh | 13.39 | P/C | 11.76 | EPS past 3/5Y | - -4.98% | ROE | 10.24% | 52W High | -26.42% ($33.44) | Perf Year | -12.98% |
| Cash/sh | 2.09 | P/FCF | 10.72 | Sales past 3/5Y | 2.42% 0.39% | ROIC | 6.39% | 52W Low | 3.14% ($23.85) | Perf 3Y | 22.25% |
| Dividend Est. | $0.99 (4.01%) | EV/EBITDA | 9.23 | EPS Y/Y TTM | 266.88% | Gross Margin | 45.93% | Volatility(W/M) | 1.61% 1.4% | Perf 5Y | -43.48% |
| Dividend TTM | 0.99 | EV/Sales | 1.48 | Sales Y/Y TTM | - | Oper. Margin | 9.12% | ATR (14) | 0.47 | Perf 10Y | -4.59% |
| Dividend Ex-Date | 2026/5/13 | Quick Ratio | 0.82 | EPS Q/Q | 62.15% | Profit Margin | 6.3% | RSI (14) | 25.14 | Recom | 2.29 |
| Dividend Gr. 3/5Y | - 0.73% | Current Ratio | 1.26 | Sales Q/Q | 3.1% | SMA20 | -7.71% ($26.66) | Beta | 0.75 | Target Price | $30.44 |
| Payout | 78.73% | Debt/Eq | 0.65 | Earnings | 2026/7/27 | SMA50 | -7.91% ($26.71) | Rel Volume | 0.8 | Prev Close | $25.02 |
| Employees | 66401 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 30.32% 0.94% | SMA200 | -11.03% ($27.65) | Avg Volume(3M) | 1.02M | Price | $24.6 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 5888 | Volume | 817,274 | Change | -1.68% |
Company
PHG is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 A Netherlands-headquartered global health technology company that supplies medical imaging equipment—including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and ultrasound—as well as image-guided therapy, patient monitoring, and personal health devices to markets worldwide. It trades on US exchanges in ADR form and is a core holding in the medical devices and digital health cycle.
Over the past 1 year, on the lower side
26% below its 1-year high.
PHG earns at a steady pace
9.12% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +0.8% this year.
Tap to view numbers
The stock looks undervalued
Trading at 18.3 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +22.3% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 4.01% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 5.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
LGHT 0.05%
HEAL 0.04%
MOTI 0.03%
EWN 0.02%
MOTG 0.02%It ranks #4 in the industry
Based on market cap of $24B.
PHG $24B PER 18.3
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is PHG?
PHG belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of PHG?
The market cap of PHG is approximately $24.0B, ranking 535 within its sector.
Does PHG pay dividends?
PHG has a dividend yield of approximately 4.01%, with an annual dividend of $0.99.
What is the P/E ratio of PHG?
PHG has a P/E ratio of approximately 18.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PHG?
PHG has recorded a 52-week high of $33.44 and a low of $23.85.
